SecBot SecBot
144 ·Filed Nov 9, 2026

REPL

Replimune Group, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1d ago SEC0001950047-26-010900
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small and by a director, not the CEO or CFO. Monitor for any subsequent Form 4 filings to confirm execution, but this filing alone does not signal a material change in insider sentiment.

DirectionNeutral
Confidencehigh
Horizonimmediate
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Joseph P. Slattery filed a Form 144 notice of intent to sell 5,200 shares of Replimune Group common stock, with an approximate market value of $113,360. The sale is small relative to the company's $1.9B market cap and represents a routine diversification move by a director.

Key Facts

  • Joseph P. Slattery, a director, filed Form 144 to sell 5,200 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $113,360.
  • Shares were acquired on 07/20/2018 via exercised shares from the issuer.
  • The proposed sale date is 11/09/2026.
  • The filing is an advance notice of intent to sell, not a completed transaction.

Financial Impact

Proposed sale of 5,200 shares worth approximately $113,360, representing less than 0.01% of the company's $1.9B market cap.

dilution

Risk Factors

  • The sale may not occur; Form 144 is an intent to sell.
  • Director-level sales are generally less informative than C-suite insider sales.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
87% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010900
Document: 0001950047-26-010900-index.html0001950047-26-010900
Document: 0001950047-26-010900.txt0001950047-26-010900

Track record

31 reports on REPL

Performance horizon

9 of 13 bullish or bearish reports moved the stock their way by T+60. Best: +188.35% at T+20 after the Jul 30, 2026 report. 13 of 14 went positive at some point.

Filters
  1. Nov 10, 2026today Insider Cluster Neutral 2/10 Entry $23.47 Now $23.28 −0.81% settles Feb 9
  2. Nov 10, 2026today SC 13G Neutral 3/10 Entry $22.00 Now $23.28 +5.82% settles Feb 8
  3. Nov 9, 20261d ago 144 Neutral 2/10 Viewing Entry $22.51 Now $23.28 +3.42% settles Feb 8
  4. Nov 9, 20261d ago SC 13G/A Neutral 2/10 Entry $22.26 Now $23.28 +4.58% settles Feb 5
  5. Nov 6, 20264d ago 10-Q/A Neutral 3/10 Entry $22.26 Now $23.28 +4.58% settles Feb 5
  6. Nov 4, 20266d ago Institutional Cluster Bearish 4/10 Entry $20.69 Now $23.28 −12.52% settles Feb 2
  7. Nov 3, 20267d ago 144 Neutral 2/10 Entry $20.69 Now $23.28 +12.52% settles Feb 2
  8. Nov 2, 20268d ago 144 Neutral 2/10 Entry $20.65 Now $23.28 +12.74% settles Feb 1
  9. Oct 30, 202611d ago 144 Neutral 2/10 Entry $19.49 Now $23.28 +19.45% settles Jan 29
  10. Oct 28, 202613d ago 144 Neutral 2/10 Entry $17.39 Now $23.28 +33.87% settles Jan 27
Showing 10 of 31

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026